CSDX — CS Diagnostics Income Statement
0.000.00%
TechnologyHighly SpeculativeMicro Cap
- $8.01m
- $7.98m
Annual income statement for CS Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | 10KSB | 10KSB | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.001 | 0.001 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 0 | 0.001 | 0.001 | 0 | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 1.26 | 1.07 | 1.12 | 0.355 | 0.231 |
Operating Profit | -1.26 | -1.07 | -1.12 | -0.355 | -0.231 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.26 | -1.09 | -1.16 | -0.402 | -0.27 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.26 | -1.09 | -1.17 | -0.402 | -0.27 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.26 | -1.09 | -1.17 | -0.402 | -0.27 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1.26 | -1.09 | -1.17 | -0.402 | -0.27 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -783,229,814 | -631,976,744 | -677,325,581 | -519,854 | -349,210 |
Dividends per Share |